Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03998618Not ApplicableCompleted

Telephone Support for Metastatic Breast Cancer Patients

Role: collaborator

NCT04518397Not ApplicableCompleted

Sankofa Paradigm: A Therapeutic Theatre Program for Girls

Role: collaborator

NCT03000751Not ApplicableCompleted

CT DOSE Collaboratory

Role: collaborator

NCT01973153Not ApplicableCompleted

The Added Value of Telephone Follow Up and Home Visits in Helping Children to Grow Up Healthy

Role: collaborator

NCT00702078Not ApplicableCompleted

Home-based Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD)

Role: collaborator

NCT01413555Not ApplicableCompleted

Multicenter Blood Culture Quality Improvement

Role: collaborator

All 6 trials loaded